Report of Three Cases of Herpes Zoster During Treatment with Natalizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Report of Three Cases of Herpes Zoster During Treatment with Natalizumab

Published:2013-02-18 Issue:4 Volume:19 Page:280-281
ISSN:1755-5930
Container-title:CNS Neuroscience & Therapeutics
language:en
Short-container-title:CNS Neurosci Ther

Author:

Fragoso Yara Dadalti,Brooks Joseph Bruno Bidin,Gomes Sidney¹,de Oliveira Francisco Tomaz Meneses¹,Gama Paulo Diniz da²

Affiliation:

1. Department of Neurology; Hospital Beneficencia Portuguesa and Hospital Paulistano; Sao Paulo; Brazil

2. Pontificia Universidade Catolica de Sao Paulo; Sao Paulo; Brazil

Publisher

Wiley

Subject

Pharmacology (medical),Physiology (medical),Psychiatry and Mental health,Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cns.12067/fullpdf

Reference10 articles.

1. Impact of natalizumab on patient-reported outcomes in multiple sclerosis: A longitudinal study;Stephenson;Health Qual Life Outcomes,2012

2. Getting to the site of inflammation: The leukocyte adhesion cascade updated;Ley;Nat Rev Immunol,2007

3. Risk of natalizumab-associated progressive multifocal leukoencephalopathy;Bloomgren;N Engl J Med,2012

4. Natalizumab and HSV meningitis;Shenoy;J Neurovirol,2011

5. Herpes encephalitis during natalizumab treatment in multiple sclerosis;Kwiatkowski;Mult Scler,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered lymphocyte profiles and herpes zoster infections in patients with multiple sclerosis on natalizumab;Multiple Sclerosis Journal;2024-06-16

2. A case of herpes zoster developing after COVID-19 vaccine and recurring after COVID-19 infection in the same dermatome;TURKDERM;2023-10-02

3. Latin American consensus recommendations on the risk of infections in people with multiple sclerosis treated with disease modifying drugs;Multiple Sclerosis and Related Disorders;2023-09

4. Real-World Data Regarding Long-Term Administration of Natalizumab Derived from a Neurology Department along with Literature Review;CNS & Neurological Disorders - Drug Targets;2022-05

5. α4-Integrin (and Other Leukocyte Integrin)-Targeting Agents;Infectious Complications in Biologic and Targeted Therapies;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3